A prospective study investigating ustekinumab concentrations through dried blood spot sampling in Crohn's disease patients
Latest Information Update: 17 Dec 2021
At a glance
- Drugs Ustekinumab (Primary) ; Ustekinumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Acronyms DUST
- 16 Dec 2021 Status changed from recruiting to completed.
- 15 Sep 2020 New trial record